Skip to content
Investing

Rigetti Computing Investor Profile: A 108-Qubit Machine, $497m of Cash and a Big Q4 Test

Rigetti Computing builds superconducting quantum computers in California and has more than $497m of cash and no debt, but its full-year target rests on one system being accepted before December ends.

Rigetti's Novera quantum processor assembly, wired into the cold stages of a dilution refrigerator.
Photo: Rigetti Computing

Rigetti Computing builds superconducting quantum computers and the chips inside them, and makes its own processors in California. It has more than $497m of cash and investments and no debt, but its revenue is still measured in single-digit millions a quarter, and its full-year target now rests on one system being accepted by a customer before the end of December.

What Rigetti does and where

Rigetti is headquartered in Berkeley, California, with operations in Fremont, California, as well as London, Adelaide, British Columbia and Thane in India, according to its latest 10-Q. Its common shares trade on Nasdaq as RGTI, and its public warrants, exercisable at $11.50 a share, trade as RGTIW.

It sells quantum computers from 9 to 108 qubits under the Novera and Cepheus names. Novera is a 9-qubit processor aimed at research groups that want a machine of their own. Cepheus-1-108Q is its largest system, built from twelve linked 9-qubit chiplets. Customers can also reach Rigetti machines through its Quantum Cloud Services platform, which connects them to public, private or hybrid clouds. Revenue comes mainly from the US and the UK, and a significant part depends on public-sector contracts.

Rigetti Computing: share price, chart and news

The latest numbers

MeasureQ3 2026Q3 2025Nine months 2026
Revenue$1.4m$1.9m$10.9m
Gross profit$0.9m$0.4m$4.4m
Operating expenses$34.0m$21.0m$91.6m
Operating loss$33.2m$20.5m$87.2m
GAAP net loss$3.1m$201.0m$22.6m
Non-GAAP net loss$20.5m$10.7m$51.2m

Rigetti reported third-quarter results on 10 November. Revenue fell about 28% from a year earlier to $1.4m, but nine-month revenue more than doubled to $10.9m from $5.2m. Research and development spending rose to $25.5m in the quarter from $15.0m.

The small GAAP net loss flatters the picture. It includes a $25.3m gain from a fall in the fair value of warrant liabilities and $4.8m of interest income. The operating loss, which excludes both, widened to $33.2m.

Rigetti still expects 2026 revenue of about $20m. That assumes customer acceptance of a system for C-DAC, and the revenue that comes with it, in the fourth quarter. With $10.9m booked in nine months, the target needs about $9.1m in the last three months, more than six times the third-quarter figure.

Cash, shares and the government stake

Balance sheet, 30 September 2026

  • $497.1m cash, cash equivalents and available-for-sale investments
  • $0 debt
  • 342.8m shares outstanding on 6 November

The cash pile is split between $45.8m in cash, $337.5m of short-term investments and $113.8m of longer-dated investments. In the first nine months, operations used $49.1m and capital spending took $42.6m. The company says existing cash is enough for at least the next twelve months. It raised no money through its at-the-market share sale programme this year, after raising $346.7m that way in the first nine months of 2025.

In September Rigetti signed a definitive agreement with the US Department of Commerce for up to $100m of CHIPS Act research funding. The money comes in three tranches of $43.9m, $29.9m and $26.2m, the later two tied to milestones, and the department received 7,739,938 shares at an implied $12.92 each. The award funds smaller readout electronics, a new cryostat design for more cooling capacity and fabrication of higher-connectivity chips. If milestones are missed, the department can demand repayment.

Warrant liabilities stood at $53.1m at the end of September, down from $102.6m at the end of 2025. Because these are revalued every quarter, they move the GAAP result: in the third quarter of 2025 the net loss was $201.0m on an operating loss of $20.5m, while this year's third quarter shows the reverse effect.

Rigetti also has a collaboration agreement with Taiwan's Quanta Computer, which bought 3.02 million Rigetti shares for $35m in a 2025 private placement. Earlier this year, revenue was stronger: the second quarter brought in $5.1m, against $1.8m a year before, which shows how lumpy sales of whole systems can be from one quarter to the next.

The technology roadmap

In the third quarter, Cepheus-1-108Q reached Rigetti's goal of 99.5% median two-qubit gate fidelity, a measure of how often a basic operation between two qubits works as intended. Smaller sections of the chip did better: 99.6% across 80 qubits and 99.7% across 50. Gate speeds are 50 to 70 nanoseconds.

The next target is a system with more than 300 qubits, about 99.7% median fidelity and gates faster than 60 nanoseconds by mid-2028. Beyond that, Rigetti aims for about 1,000 qubits at about 99.9% fidelity within roughly three years, packing more qubits into a single dilution refrigerator rather than linking several.

Risks to weigh

  • Tiny revenue, big costs. Quarterly operating expenses of $34.0m compare with revenue of $1.4m.
  • One deal decides the year. The $20m target depends on C-DAC acceptance in the fourth quarter.
  • Government dependence. Public-sector contracts can be ended early, audited or delayed, and the Commerce award comes with repayment and domestic production conditions.
  • Dilution. Warrants, share-based pay and past share sales have raised the share count; new funding would add more.
  • Competition. Larger companies are working on rival quantum technologies.
  • Rising compliance costs. Rigetti will no longer be an emerging growth company from 31 December 2026.

What to watch next

WhenWhat
Q4 2026Customer acceptance of the C-DAC system and about $9.1m of revenue needed to reach the $20m target
31 December 2026Emerging growth company status ends
Through 2031Milestones that release the second and third Commerce tranches
Mid-2028Target for a 300-plus-qubit system at about 99.7% fidelity
About 2029Target of about 1,000 qubits at about 99.9% fidelity

Sources

Related stories

Business

Rigetti Computing Signs a $100m US Commerce Deal That Gives Washington an Equity Stake

Rigetti Computing signed a definitive deal for up to $100m of US CHIPS Act research funding, paid in three milestone tranches, and is issuing 7.74m shares to the Commerce…

Investing

D-Wave Quantum: Investor Profile of the Annealing Pioneer Building a Gate-Model Machine

D-Wave Quantum sells quantum computing through the cloud, on-site systems and services. It holds $503m of cash and securities and a growing order book, but its losses keep rising.

Investing

Quantum Computing Inc.: Investor Profile of the Photonics Maker With $1.3bn in the Bank

Quantum Computing Inc. sells photonic chips, packaging services and room-temperature quantum optimisation machines. It has about $1.3bn in cash and investments, but sales are small…

Investing

Redwire Profile: Space Solar Arrays, Military Drones and a $620m Order Book

How Redwire earns its money from space solar arrays, spacecraft and military drones, what its third-quarter filing shows on backlog, cash and dilution, and what to watch into late…

Investing

Aya Gold & Silver Corrects Q3 Cash Costs to $14.28 an Ounce After Silver Double Count

Aya Gold & Silver refiled its Q3 MD&A after silver in transit was deducted twice. Zgounder ounces sold rise to 1,392,478 and cash costs fall to $14.28 from $15.51. Revenue and…

Investing

FDA Rejects Summit's Lung Cancer Drug Ivonescimab Over Phase 3 Survival Miss

The FDA has rejected Summit Therapeutics' lung cancer drug ivonescimab, saying slower tumour growth in the phase 3 HARMONi trial was not enough without a clear gain in survival.

Investing

Red Cat Withdraws Its $150m to $180m 2026 Revenue Target After $11.8m Third Quarter

Red Cat Holdings has withdrawn its $150m to $180m revenue target for 2026 after third-quarter sales of $11.8m, blaming slower defence funding. Its quarterly net loss more than…

Investing

Berkshire Reveals $689m Bending Spoons Stake, Doubles Lennar and Trims Bank of America Again

Berkshire Hathaway's third-quarter 13F shows a new Bending Spoons stake worth $689m, a doubled Lennar holding and 27.5 million more Bank of America shares sold, while Apple stayed…